Gold nanostructures |
Spike protein |
5 µg·mL–1
|
[63]
|
Gold nanostructures |
Spike protein |
80 copies mL−1 in contaminated water |
[64]
|
Gold nanostructures |
anti-SARS-CoV-2 IgG |
Semi-quantitative |
[37]
|
Gold nanostructures |
RNA |
4 copies/µL |
[65]
|
Gold nanostructures |
N gene and E gene |
300 copies/µL of E gene; 225 copies/µL of N gene |
[66]
|
Gold nanostructures |
Viral proteins of SARS-CoV-2 trapped in surgical face masks |
3 ng mL−1
|
[62]
|
Gold nanostructures |
RNA |
50 RNA copies per reaction |
[67]
|
Gold nanostructure |
16S rRNAs; N gene |
(Not Reported) |
[68]
|
Gold nanostructures |
anti-SARS-CoV-2 IgG antibodies |
3.2 nM |
[69]
|
Gold nanostructures |
N gene |
0.18 ng/µL |
[39]
|
Gold nanostructures |
Viral particles |
Viral loads corresponding to Ct = 36.5 |
[38]
|
Gold nanostructures |
RNA |
10 copies/µL |
[70]
|
Gold nanostructures |
anti-SARS-CoV-2 IgM |
(Not reported) |
[55]
|
Gold nanostructures |
Highly conserved nucleoprotein |
250 pg/mL |
[56]
|
Gold nanostructures |
anti-SARS-CoV-2 IgG |
(Not reported) |
[57]
|
Gold nanostructures |
Volatile organic compounds from breath |
(Not reported) |
[58]
|
Gold Nano star |
Spike protein and the virus |
130 fg/mL for antigen and 8 particles/mL for virus |
[71]
|
Gold nanoislands |
RNA |
0.22 pM |
[44]
|
Gold nanoisland films |
RNA |
2.98 copies µL−1
|
[72]
|
Gold nanostructures and spherical nucleic acid |
RNA |
(Not reported) |
[73]
|
Gold nanostructures and spherical nucleic acid |
RNA |
Six copies of ssDNA per reaction |
[36]
|
Gold nanostructures and graphite |
Spike protein |
229 fg mL−1
|
[74]
|
Gold and silver nanostructures |
Spike protein |
0.77 fg mL−1 in PBS; 6.07 fg mL−1 in saliva; 7.60 fg mL−1 in serum; and 0.10 pg mL−1 in blood |
[75]
|
(Not Reported) |
SARS-CoV-2 total antibody |
(Not Reported) |
[76]
|
Gold-platinum core-shell nanostructures |
Subunit S1 of spike protein (S) |
11 ng mL−1
|
[77]
|
Gold nanostructure (AuNP)-decorated graphene field-effect transistor (G-FET) sensor |
RNA |
0.37 fM in PBS; 2.29 fM in throat swab; and 3.99 fM in serum |
[50]
|
Super paramagnetic nanostructures |
anti-SARS-CoV-2 IgM and IgG |
10 ng/mL for IgM and 5 ng/mL for IgG |
[78]
|
Lanthanide-doped nanostructures |
anti-SARS-CoV-2 IgG |
(Not Reported) |
[79]
|
Selenium nanostructures |
anti-SARS-CoV-2 IgM and IgG |
20 ng/mL for IgM and 5 ng/mL for IgG |
[46]
|
Au/Ag coated carbon nanotubes |
Live virus |
(Not Reported) |
[41]
|
Europium-chelate-based fluorescent nanostructures |
RNA |
1,000 TU (transduction units) mL−1
|
[80]
|
Ag shell on SiO2 core (SiO2@Ag) |
anti-SARS-CoV-2 IgM/IgG |
1 pg/mL |
[43]
|
(Not Reported) |
Total antibody (IgA, IgM, and IgG) against SARS-CoV-2 |
(Not Reported) |
[81]
|
Cobalt functionalized-TiO2 nanotube |
RBD domain of S protein |
~0.7 nM |
[47]
|
Carbon black |
Spike (S) protein or Nucleocapsid (N) protein |
19 ng/mL for S protein; 8 ng/mL for N protein |
[60]
|
Carbon nanotubes |
RNA |
6.4 copies/µL in PBS and 9.2 copies/µL in 50% human saliva |
[48]
|
Graphene |
Spike protein |
1.6 × 101 pfu/mL in culture medium; 2.42 × 102 copies/mL in clinical samples; 1 fg/mL in phosphate-buffered saline; 100 fg/mL in clinical transport medium |
[49]
|
Graphene |
Spike protein |
∼3.75 and ∼1 fg/mL in artificial saliva and phosphate-buffered saline, respectively |
[82]
|
Reduced-graphene-oxide Nano flakes |
Antibodies to spike S1 protein and its receptor-binding-domain (RBD) |
2.8 × 10−15 M for spike S1 protein and 16.9 × 10−15 M receptor-binding-domain |
[51]
|
Quantum dot |
Antibodies |
17.5 pM for nucleocapsid antibody and 24.4 pM for S1 antibody |
[83]
|
Quantum dot Nano beads |
SARS-CoV-2 total antibody |
(Not Reported) |
[84]
|
Enzyme-DNA hybrid Nano complexes |
RNA |
~8 RNA copies/µL |
[85]
|
Streptavidin coated polymer nanostructures |
ORF1ab and N gene |
12 copies per reaction |
[45]
|
Aggregation-induced emission (AIE) dye-loaded nanostructure |
anti-SARS-CoV-2 IgM and IgG |
0.236 mL–1 for IgM; 0.125 µg mL–1 for IgG |
[86]
|